| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
WIG
|
Matthew Hemming
|
||||||
| GSE235737 |
Alveolar Soft Part Sarcoma is driven by ASPSCR1::TFE3-dependent and therapeutically targetable transcriptional programs [ChIP-Seq]
|
17 |
|
Matthew Hemming | Apr 19, 2024 | |||
| GSE235739 |
ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs
|
62 |
|
Matthew Hemming | Apr 19, 2024 | |||
| GSE255962 |
Alveolar Soft Part Sarcoma is driven by ASPSCR1::TFE3-dependent and therapeutically targetable transcriptional programs [ATAC-Seq]
|
10 |
|
Matthew Hemming | Apr 19, 2024 | |||
| GSE172152 |
MOZ and Menin-MLL Complexes are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor [ChIP-seq and CUT&Tag]
|
15 |
|
Matthew Hemming | May 02, 2022 | |||
| GSE172154 |
MOZ and Menin-MLL Complexes are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor
|
78 |
|
Matthew Hemming | May 02, 2022 | |||
| GSE113207 |
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [ChIP-seq]
|
18 |
|
Matthew Hemming | Jan 23, 2019 | |||
| GSE113217 |
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition
|
36 |
|
Matthew Hemming | Jan 23, 2019 | |||
| GSE95861 |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome
|
2 |
|
Matthew Hemming | May 21, 2018 | |||
| GSE95862 |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome
|
52 |
|
Matthew Hemming | May 21, 2018 | |||
| GSE95864 |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome
|
74 |
|
Matthew Hemming | May 21, 2018 |
